SCHEMBL5702091

SCHEMBL5702091

O=CC(Br)c1ccc(OCc2ccccc2)c(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.50
RAB9A P51151 5/20 0.50
SMN1; SMN2 Q16637 5/20 0.50
NFKB1 P19838 2/20 0.50
NFKB2 Q00653 2/20 0.50
RELA Q04206 2/20 0.50
ACP1 P24666 1/20 0.47
PTPN12 Q05209 1/20 0.47
PTPN13 Q12923 1/20 0.47
SSU72 Q9NP77 1/20 0.47
HPGD P15428 4/20 0.46
PPARG P37231 1/20 0.46
TP53 P04637 2/20 0.44
XBP1 P17861 2/20 0.44
MAPT P10636 2/20 0.44
HTT P42858 1/20 0.44
HSD17B10 Q99714 1/20 0.44
EGFR P00533 1/20 0.44
MRGPRX4 Q96LA9 8/20 0.44
MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10477773 0.87 L3MBTL1 (0.43) NPC1RAB9ASMN1; SMN2MAPTMEN1
SCHEMBL5702073 0.84 FFAR4 (0.50) NPC1RAB9ASMN1; SMN2MAPTMRGPRX4
SCHEMBL6874912 0.83 HPGD (0.51) NPC1RAB9ASMN1; SMN2HPGDHTT
SCHEMBL22325359 0.81 FFAR1 (0.41) NPC1RAB9ASMN1; SMN2MAPTL3MBTL1
SCHEMBL4286871 0.80 POLB (0.50) NPC1RAB9ASMN1; SMN2HPGDMAPT
SCHEMBL21199371 0.79 CCNB2 (0.43) NPC1RAB9ASMN1; SMN2MAPTHTR1A
SCHEMBL10172543 0.79 NPC1 (0.52) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL22469829 0.78 MRGPRX4 (0.71) MRGPRX4
SCHEMBL27618166 0.78 ALDH1A1 (0.48) SMN1; SMN2HPGDMAPTHTTL3MBTL1
SCHEMBL20445938 0.77 MAPT (0.42) NPC1RAB9ASMN1; SMN2NFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1673366-A1 1-\"2-(4-HYDROXYPHENYL)-2-HYDROXYETHYL]-PIPERIDIN-4-OL COMPOUNDS AS NMDA RECEPTOR ANTAGONISTS Pfizer, Inc. (US) 2006-06-28 EP disclosed
WO-2005035522-A1 1-‘2-(4-HYDROXYPHENYL)-2-HYDROXYETHYL!-PIPERIDIN-4-OL COMPOUNDS AS NMDA RECEPTOR ANTAGONISTS PFIZER JAPAN, INC. (JP) 2005-04-21 WO disclosed